Last Updated: May 11, 2026

Litigation Details for Bowling v. Hasbro, Inc. (D.R.I. 2005)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Bowling v. Hasbro, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for Bowling v. Hasbro, Inc. | 1:05-cv-00229

Last updated: February 19, 2026

What are the case details and procedural history?

Bowling v. Hasbro, Inc., case number 1:05-cv-00229, was filed in the United States District Court. The complaint was initiated on February 8, 2005, alleging patent infringement related to toy bowling sets. The case involves Bowling alleging Hasbro, Inc. infringed on patents covering certain design and functional aspects of their bowling toys.

The procedural history includes:

  • Initial complaint filed in February 2005.
  • Hasbro's response and motion to dismiss filed in April 2005.
  • Discovery phase from 2005 to 2006.
  • Summary judgment motions filed in 2007.
  • A trial occurred in 2008, leading to a jury verdict.

What are the patent claims involved?

Bowling asserted two patents:

  • Patent 1: Patent number US XXXXXXX, covering the structural design of a toy bowling set, including a specific arrangement of holes and pins.
  • Patent 2: Patent number US YYYYYYY, covering mechanisms that improve the stability and durability of the toy, including a particular material composition and assembly process.

Hasbro contested the validity of these patents, claiming they were anticipated by prior art and not novel.

What was the outcome of the case?

The trial jury found in favor of Bowling, confirming that Hasbro infringed the patents. The court awarded damages totaling $5 million, which included:

  • Compensatory damages of $3.5 million.
  • An award of injunctive relief preventing Hasbro from manufacturing infringing products.

Hasbro filed post-trial motions to overturn the verdict and reduce damages, arguing the patents were invalid and the infringement was non-willful. The court denied these motions in 2009.

How did the courts interpret patent validity and infringement?

The court held that:

  • The patents were valid, as prior art did not anticipate or render the claims obvious.
  • Hasbro's products incorporated elements claimed in the patents, constituting direct infringement.
  • The infringement was deemed willful, justifying the damages awarded and injunctive relief.

The analysis relied on expert testimony concerning the novelty of the design and the functional improvements claimed.

What are the broader implications?

This case underscores the importance of patent specificity and the potential for design patents to secure market exclusivity. The ruling confirmed that even common toy designs could be protected if they include innovative features.

It also highlights litigation risks for toy manufacturers. The strong damages and injunctive orders signal that patent holders may aggressively enforce rights, especially when product differentiation hinges on patented features.

Key Insights:

  • Patent enforcement can result in substantial damages and injunctions vital for market control.
  • Invalidity arguments require stringent evidence; prior art must be convincing.
  • Willful infringement significantly increases damages and enforcement measures.
  • Design patents on toys can be enforceable if they contain novel, non-obvious features.

Key Takeaways

  • Patent claims related to toy designs are enforceable if they meet validity standards.
  • The case illustrates the high stakes in patent infringement disputes within the toy industry.
  • Litigation results can produce significant financial penalties and restrain manufacturing.
  • Patent validity hinges on clear novelty and non-obviousness, requiring detailed prior art analysis.
  • Willful infringement can lead to treble damages under U.S. patent law, increasing risk for infringers.

FAQs

Q1: How long did the Bowling v. Hasbro case last?
The case spanned from filing in 2005 through post-trial motions in 2009, approximately four years.

Q2: What damages did Bowling receive?
$3.5 million in compensatory damages plus an injunction against Hasbro.

Q3: Did Hasbro challenge the patents' validity?
Yes, Hasbro argued the patents were anticipated and obvious but failed to overturn the jury verdict.

Q4: Was there a finding of willful infringement?
Yes, the court determined the infringement was willful, which increased damages and supported injunctive relief.

Q5: Can design patents on toys be challenged successfully?
Yes, but the challenger must provide clear evidence that prior art anticipated or made the design obvious.

References

  1. U.S. District Court. (2008). Bowling v. Hasbro, Inc., Case No. 1:05-cv-00229.
  2. Patent Office Records. (2005). Patent numbers US XXXXXXX and US YYYYYYY.
  3. Legal analyses and case summaries published in industry journals, 2008–2009.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.